To meet the clinical needs in women’s health, we are developing two innovative diagnostic platforms that can be used to detect major health conditions.
The first is based on exosomes and functions as a new way to leverage the body’s natural cell signaling and intercellular communication pathways. Given the presence of exosomes in all body fluids, this approach provides us with a novel way to generate a “bio-fingerprint” that is predictive of future health risk for the patient.
The second is based on multiomics. This is an innovative and integrated approach to diagnostics that includes the analysis of the proteome, transcriptome, epigenome and microbiome. Data from these diverse set of technologies are analyzed using advanced artificial intelligence and coalesced in a single clinical test result that empowers the healthcare provider with a clear clinical course of action.
Company Details
- Address
- 340 Madison Ave,
- Industry
- Biotechnology
- Website
- milulabs.com
- Keywords
- diagnostics, exosomes, women's health, multiomics.
- HQ
- New York
Milu Labs Questions
Milu Labs's website is milulabs.com
Milu Labs's LinkedIn profile is https://www.linkedin.com/company/milu-labs
Milu Labs's industry is
Biotechnology
Milu Labs's top competitors are
Inex Innovate,
Momsanity App,
Azure Biotech Inc.,
May Health,
Luca Biologics,
Vermilion Therapeutics Inc.,
Medisix Therapeutics,
Koko Medical, Inc.,
Intelligenome,
S1 Biopharma.
Milu Labs's categories are Biotechnology
